Please log in to view this page
Username
Password
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...